Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction on Monday, April 21st. The stock was sold at an average price of $33.34, for a total transaction of $133,360.00. Following the sale, the chief executive officer now owns 118,784 shares in the company, valued at $3,960,258.56. This represents a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Margaret Tooth also recently made the following trade(s):
- On Thursday, March 20th, Margaret Tooth sold 4,000 shares of Trupanion stock. The shares were sold at an average price of $37.17, for a total value of $148,680.00.
- On Tuesday, March 4th, Margaret Tooth sold 2,294 shares of Trupanion stock. The stock was sold at an average price of $31.39, for a total value of $72,008.66.
Trupanion Price Performance
Shares of TRUP opened at $35.68 on Thursday. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The stock's 50 day moving average is $35.90 and its two-hundred day moving average is $45.38. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The firm has a market capitalization of $1.52 billion, a PE ratio of -155.13, a P/E/G ratio of 6.02 and a beta of 1.66.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Research analysts anticipate that Trupanion, Inc. will post 0.13 earnings per share for the current year.
Institutional Investors Weigh In On Trupanion
A number of hedge funds and other institutional investors have recently modified their holdings of TRUP. Balyasny Asset Management L.P. raised its holdings in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock worth $40,548,000 after purchasing an additional 661,559 shares during the last quarter. BNP Paribas Financial Markets boosted its position in shares of Trupanion by 170.7% in the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after buying an additional 212,545 shares in the last quarter. Freestone Grove Partners LP acquired a new stake in Trupanion in the 4th quarter valued at about $7,776,000. Baillie Gifford & Co. increased its holdings in Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider's stock valued at $33,806,000 after acquiring an additional 147,341 shares in the last quarter. Finally, First Trust Advisors LP acquired a new position in Trupanion during the fourth quarter worth about $7,083,000.
Analyst Ratings Changes
A number of equities analysts have recently commented on TRUP shares. Stifel Nicolaus cut their target price on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a report on Thursday, February 20th. Piper Sandler decreased their target price on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Trupanion presently has a consensus rating of "Moderate Buy" and an average target price of $46.60.
View Our Latest Stock Report on Trupanion
About Trupanion
(
Get Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
